Free Trial

Waters (WAT) Competitors

Waters logo
$285.23 +5.94 (+2.13%)
Closing price 08/12/2025 03:59 PM Eastern
Extended Trading
$285.14 -0.09 (-0.03%)
As of 08/12/2025 06:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

WAT vs. BRKR, TECH, A, DHR, IQV, MTD, RVTY, TMO, ILMN, and CRL

Should you be buying Waters stock or one of its competitors? The main competitors of Waters include Bruker (BRKR), Bio-Techne (TECH), Agilent Technologies (A), Danaher (DHR), IQVIA (IQV), Mettler-Toledo International (MTD), Revvity (RVTY), Thermo Fisher Scientific (TMO), Illumina (ILMN), and Charles River Laboratories International (CRL).

Waters vs. Its Competitors

Waters (NYSE:WAT) and Bruker (NASDAQ:BRKR) are both life sciences tools & services companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk.

94.0% of Waters shares are owned by institutional investors. Comparatively, 79.5% of Bruker shares are owned by institutional investors. 0.8% of Waters shares are owned by insiders. Comparatively, 27.3% of Bruker shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Waters presently has a consensus price target of $378.73, suggesting a potential upside of 32.78%. Bruker has a consensus price target of $51.30, suggesting a potential upside of 58.53%. Given Bruker's higher possible upside, analysts plainly believe Bruker is more favorable than Waters.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Waters
0 Sell rating(s)
9 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.47
Bruker
0 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.45

Waters has a net margin of 21.71% compared to Bruker's net margin of 2.31%. Waters' return on equity of 38.60% beat Bruker's return on equity.

Company Net Margins Return on Equity Return on Assets
Waters21.71% 38.60% 15.87%
Bruker 2.31%17.89%5.38%

In the previous week, Waters had 18 more articles in the media than Bruker. MarketBeat recorded 51 mentions for Waters and 33 mentions for Bruker. Waters' average media sentiment score of 0.57 beat Bruker's score of -0.01 indicating that Waters is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Waters
20 Very Positive mention(s)
5 Positive mention(s)
12 Neutral mention(s)
4 Negative mention(s)
4 Very Negative mention(s)
Positive
Bruker
6 Very Positive mention(s)
9 Positive mention(s)
5 Neutral mention(s)
3 Negative mention(s)
2 Very Negative mention(s)
Neutral

Waters has higher earnings, but lower revenue than Bruker. Waters is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Waters$2.96B5.74$637.83M$11.0925.72
Bruker$3.44B1.43$113.10M$0.5262.23

Waters has a beta of 1.04, meaning that its share price is 4% more volatile than the S&P 500. Comparatively, Bruker has a beta of 1.16, meaning that its share price is 16% more volatile than the S&P 500.

Summary

Waters beats Bruker on 11 of the 16 factors compared between the two stocks.

Get Waters News Delivered to You Automatically

Sign up to receive the latest news and ratings for WAT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WAT vs. The Competition

MetricWatersMED INSTRUMENTS IndustryMedical SectorNYSE Exchange
Market Cap$16.62B$6.91B$5.49B$20.66B
Dividend YieldN/A1.33%4.64%3.66%
P/E Ratio25.7224.8530.3928.37
Price / Sales5.7466.68448.3660.19
Price / Cash18.4721.2037.7222.93
Price / Book7.865.598.305.38
Net Income$637.83M$176.29M$3.26B$994.60M
7 Day Performance2.60%1.71%1.46%1.47%
1 Month Performance-19.18%-1.33%3.65%0.48%
1 Year Performance-15.82%11.11%40.97%14.95%

Waters Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WAT
Waters
4.7784 of 5 stars
$285.23
+2.1%
$378.73
+32.8%
-14.5%$16.62B$2.96B25.727,600Trending News
BRKR
Bruker
4.9442 of 5 stars
$34.72
-8.6%
$53.60
+54.4%
-46.4%$5.26B$3.37B66.7711,396Trending News
Dividend Announcement
High Trading Volume
TECH
Bio-Techne
4.9251 of 5 stars
$54.88
0.0%
$69.58
+26.8%
-26.4%$8.60B$1.16B66.933,100Earnings Report
Dividend Announcement
A
Agilent Technologies
4.6854 of 5 stars
$114.99
+1.3%
$139.77
+21.5%
-13.5%$32.67B$6.63B28.3917,900Positive News
DHR
Danaher
4.8889 of 5 stars
$197.50
+0.2%
$247.61
+25.4%
-23.0%$141.42B$23.88B42.0263,000Positive News
IQV
IQVIA
4.7394 of 5 stars
$182.97
+0.3%
$228.62
+24.9%
-19.6%$31.10B$15.70B26.4888,000News Coverage
Positive News
MTD
Mettler-Toledo International
3.8445 of 5 stars
$1,230.69
+2.8%
$1,300.00
+5.6%
-6.3%$25.57B$3.87B31.1617,300News Coverage
Positive News
Insider Trade
RVTY
Revvity
2.9586 of 5 stars
$88.34
+0.1%
$120.07
+35.9%
-25.4%$10.41B$2.76B37.4311,000Positive News
TMO
Thermo Fisher Scientific
4.9735 of 5 stars
$467.41
+0.9%
$593.00
+26.9%
-20.3%$176.44B$42.88B27.03125,000Positive News
Analyst Downgrade
ILMN
Illumina
4.8417 of 5 stars
$98.44
+4.0%
$127.47
+29.5%
-21.8%$15.58B$4.28B12.469,030Positive News
Analyst Downgrade
CRL
Charles River Laboratories International
4.6186 of 5 stars
$167.74
+0.5%
$174.54
+4.1%
-21.4%$8.24B$4.02B-258.0620,100Earnings Report
Analyst Upgrade
Analyst Revision

Related Companies and Tools


This page (NYSE:WAT) was last updated on 8/13/2025 by MarketBeat.com Staff
From Our Partners